Literature DB >> 15920733

CD46 on glial cells can function as a receptor for viral glycoprotein-mediated cell-cell fusion.

Riccardo Cassiani-Ingoni1, Heather L Greenstone, Donatella Donati, Anna Fogdell-Hahn, Elena Martinelli, Daniel Refai, Roland Martin, Edward A Berger, Steven Jacobson.   

Abstract

Membrane cofactor protein (CD46) is a regulator of complement activation that also serves as the entry receptor for human herpes virus 6 (HHV-6) and measles virus (MV) into human cells. While it is clear that oligodendrocytes and astrocytes are cell types commonly infected by these viruses, it is unclear whether oligodendrocytes express CD46, or which are the cellular mechanisms underlying the infection. We show that adult oligodendrocytes, as well as astrocytes and microglial cells, express CD46 on the cellular surface. Moreover, we employed a quantitative fusion assay to demonstrate that HHV-6A infection of T lymphocytes enables cell-cell fusion of these cells to astrocytes or to oligodendroglial cells. This fusion is mediated by the interaction between viral glycoproteins expressed on the membrane of the infected cells and CD46 on the glial targets, and is also observed using cells expressing recombinant MV glycoproteins. These data suggest a mechanism that involves cell-cell fusion by which certain viruses could spread the infection from the periphery to the cells in the nervous system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920733     DOI: 10.1002/glia.20219

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  11 in total

1.  Experimental measles encephalitis in Lewis rats: dissemination of infected neuronal cell subtypes.

Authors:  Ulrike Jehmlich; Jennifer Ritzer; Jens Grosche; Wolfgang Härtig; Uwe G Liebert
Journal:  J Neurovirol       Date:  2013-08-31       Impact factor: 2.643

2.  Induction of cell-cell fusion from without by human herpesvirus 6B.

Authors:  Simon Metz Pedersen; Bodil Oster; Bettina Bundgaard; Per Höllsberg
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Human herpesvirus-6 entry into the central nervous system through the olfactory pathway.

Authors:  Erin Harberts; Karen Yao; Jillian E Wohler; Dragan Maric; Joan Ohayon; Robert Henkin; Steven Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

Review 4.  CD46 plasticity and its inflammatory bias in multiple sclerosis.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-01-26       Impact factor: 4.291

5.  U20 is responsible for human herpesvirus 6B inhibition of tumor necrosis factor receptor-dependent signaling and apoptosis.

Authors:  Emil Kofod-Olsen; Katrine Ross-Hansen; Mariane Høgsbjerg Schleimann; Dea Kejlberg Jensen; Janni Michelle Lund Møller; Bettina Bundgaard; Jacob Giehm Mikkelsen; Per Höllsberg
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

6.  Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis.

Authors:  Silvia S Borkosky; Corinna Whitley; Annette Kopp-Schneider; Harald zur Hausen; Ethel-Michele de Villiers
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

7.  Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantation.

Authors:  J A Hill; M Boeckh; W M Leisenring; H Xie; A L Adler; M-L Huang; J R Fann; C Delaney; D M Zerr
Journal:  Bone Marrow Transplant       Date:  2015-06-29       Impact factor: 5.483

8.  GP96 interacts with HHV-6 during viral entry and directs it for cellular degradation.

Authors:  Bhupesh K Prusty; Christine Siegl; Nitish Gulve; Yasuko Mori; Thomas Rudel
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

Review 9.  The role of herpesvirus 6A and 6B in multiple sclerosis and epilepsy.

Authors:  Nicky Dunn; Nastya Kharlamova; Anna Fogdell-Hahn
Journal:  Scand J Immunol       Date:  2020-10-23       Impact factor: 3.487

Review 10.  Viral infections and multiple sclerosis.

Authors:  Donatella Donati
Journal:  Drug Discov Today Dis Models       Date:  2020-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.